Catatonia is not schizophrenia and it is treatable

被引:8
作者
Appiani, Francisco J. [1 ]
Castro, Gonzalo S. [2 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose de San Martin, Direct Teaching & Res, Program Pharmacol, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Clin Jose de San Martin, Program Abnormal Movements & Parkinson Dis, Neurol Div,Fellowship Abnormal Movements, Buenos Aires, DF, Argentina
关键词
Catatonia; Lorazepam; Electroconvulsive therapy;
D O I
10.1016/j.schres.2017.05.030
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Catatonia is a cluster of motor features that appears in many recognized psychiatric illnesses, that according to the DSM-5 it is not linked as a subtype to schizophrenia anymore. The classic signs are mutism, a rigid posture, fixed staring, stereotypic movements, and stupor, which are all part of a broad psychopathology that may be found in affective, thought, neurological, toxic, metabolic and immunological disorders. Despite the many etiologies, catatonia may be a life-threatening condition with a specific treatment. Benzodiazepines are the first line therapeutic option for catatonia, being lorazepam the first-choice drug. Eighty percent of the patients are relieved by the use of barbiturates or benzodiazepines, while in those who fail, an improvement is achieved by electroconvulsive therapy (ECT). With more than 60 years of use in catatonic patients, ECT has proven to be an effective and safe tool for the treatment of this frequent and sometimes forgotten syndrome. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 63 条
  • [1] ECT in Pregnancy: A Review of the Literature From 1941 to 2007
    Anderson, Eric L.
    Reti, Irving M.
    [J]. PSYCHOSOMATIC MEDICINE, 2009, 71 (02): : 235 - 242
  • [2] [Anonymous], 2013, DIAGNOSTIC STAT MANU, VFifth, P1000, DOI DOI 10.1176/APPI.BOOKS.9780890425596
  • [3] [Anonymous], PRACT EL THER REC TR
  • [4] Response to clozapine in acute mania is more rapid than that of chlorpromazine
    Barbini, B
    Scherillo, P
    Benedetti, F
    Crespi, G
    Colombo, C
    Smeraldi, E
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (02) : 109 - 112
  • [5] THE INFLUENCE OF NEUROLEPTICS ON SPECIFIC SYNDROMES AND SYMPTOMS IN SCHIZOPHRENICS WITH UNFAVORABLE LONG-TERM COURSE - A 5-YEAR FOLLOW-UP-STUDY OF 50 CHRONIC-SCHIZOPHRENICS
    BECKMANN, H
    FRITZE, J
    FRANZEK, E
    [J]. NEUROPSYCHOBIOLOGY, 1992, 26 (1-2) : 50 - 58
  • [6] Narcosis as therapy in neuropsychiatric conditions
    Bleckwenn, WJ
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1930, 95 : 1168 - 1171
  • [7] Catatonia .2. Treatment with lorazepam and electroconvulsive therapy
    Bush, G
    Fink, M
    Petrides, G
    Dowling, F
    Francis, A
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1996, 93 (02) : 137 - 143
  • [8] Catatonia .1. Rating scale and standardized examination
    Bush, G
    Fink, M
    Petrides, G
    Dowling, F
    Francis, A
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1996, 93 (02) : 129 - 136
  • [9] Caroff, 2004, CATATONIA PSYCHOPATH
  • [10] Catatonia and consultation-liaison psychiatry study of 12 cases
    Cottencin, Olivier
    Warembourg, Frederique
    de Lenclave, Marie Brengere De Chouly
    Lucas, Bemard
    Vaiva, Guillaume
    Goudemand, Michel
    Thomas, Pierre
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (06) : 1170 - 1176